| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013250541 |
| P356 | DOI | 10.1038/301069A0 |
| P953 | full work available at URL | http://www.nature.com/articles/301069a0 |
| http://www.nature.com/articles/301069a0.pdf | ||
| P3181 | OpenCitations bibliographic resource ID | 4123589 |
| P698 | PubMed publication ID | 6296685 |
| P50 | author | Paul Greengard | Q309979 |
| P2093 | author name string | D. W. Aswad | |
| S. I. Walaas | |||
| P2860 | cites work | Harvey lectures | Q27711052 |
| Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis | Q29547747 | ||
| A simplification of the protein assay method of Lowry et al. which is more generally applicable | Q29615220 | ||
| Multiple phosphorylation sites in protein I and their differential regulation by cyclic AMP and calcium | Q34039735 | ||
| Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". | Q34721196 | ||
| Cyclic nucleotides and nervous system function | Q35854598 | ||
| Depolarizing agents and cyclic nucleotides regulate the phosphorylation of specific neuronal proteins in rat cerebral cortex slices | Q35996834 | ||
| Regulation of phosphorylation of proteins I, IIIa, and IIIb in rat neurohypophysis in vitro by electrical stimulation and by neuroactive agents | Q36314990 | ||
| Dopamine and depolarizing agents regulate the state of phosphorylation of protein I in the mammalian superior cervical sympathetic ganglion | Q36420230 | ||
| Multiple receptors for dopamine | Q37876912 | ||
| Dopamine-Sensitive Adenylate Cyclase Occurs in a Region of Substantia Nigra Containing Dopaminergic Dendrites | Q40004311 | ||
| Localization of GABAergic, cholinergic and aminergic structures in the mesolimbic system | Q40652109 | ||
| Analytical characterization of beetroot vacuole membrane | Q41275378 | ||
| [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain | Q41622976 | ||
| Preparation of homogeneous cyclic AMP-dependent protein kinase(s) and its subunits from rabbit skeletal muscle | Q44848566 | ||
| Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity | Q47868385 | ||
| Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'? | Q48363679 | ||
| Serotonin stimulates phosphorylation of protein I in the facial motor nucleus of rat brain | Q71530231 | ||
| Presence of protein I, a phosphoprotein associated with synaptic vesicles, in cerebellar granule cells | Q71553315 | ||
| P433 | issue | 5895 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| dopamine | Q170304 | ||
| P304 | page(s) | 69–71 | |
| P577 | publication date | 1983-01-06 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions | |
| P478 | volume | 301 |
| Q48329693 | A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. |
| Q30541064 | A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice |
| Q36288480 | A mathematical tool for exploring the dynamics of biological networks |
| Q28508656 | A phosphatase cascade by which rewarding stimuli control nucleosomal response |
| Q36255274 | A quantitative dot-immunobinding assay for proteins using nitrocellulose membrane filters |
| Q34892958 | A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. |
| Q48965778 | A specific effect of antipsychotic drugs on protein synthesis in human lymphomononuclear cells |
| Q41784558 | ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase). |
| Q49135033 | ARPP-21, a cAMP-regulated phosphoprotein enriched in dopamine-innervated brain regions: tissue distribution and regulation of phosphorylation in rat brain |
| Q48382393 | ARPP-39, a membrane-associated substrate for cyclic AMP-dependent protein kinase present in neostriatal neurons |
| Q30488182 | Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice |
| Q28236649 | Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices |
| Q33770744 | Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters |
| Q33976360 | Acute Ca(2+)-dependent desensitization of 5-HT(1A) receptors is mediated by activation of protein kinase A (PKA) in rat serotonergic neurons |
| Q46212807 | An adaptive role of TNFα in the regulation of striatal synapses |
| Q48737418 | Apomorphine is a potent inhibitor of type 2A protein phosphatase in rat brain |
| Q47361231 | Associations Between PPP1R1B Gene Polymorphisms and Anxiety Levels in the Chinese Population |
| Q46621116 | Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero |
| Q34976214 | BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity. |
| Q48576859 | Behavioral expression of cocaine sensitization in rats is accompanied by a distinct pattern of modifications in the PKA/DARPP-32 signaling pathway |
| Q35182543 | Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases |
| Q48617260 | Bidirectional regulation of DARPP-32 phosphorylation by dopamine. |
| Q28272251 | Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons |
| Q41478832 | Cellular localization and function of DARPP-32 in the rodent retina |
| Q48870418 | Characterization in mammalian brain of a DARPP-32 serine kinase identical to casein kinase II. |
| Q39144533 | Characterization of a novel cell line from the caudal fin of koi carp Cyprinus carpio |
| Q48943508 | Chronic treatment of rats with SCH-23390 or raclopride does not affect the concentrations of DARPP-32 or its mRNA in dopamine-innervated brain regions |
| Q48700733 | Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen |
| Q46981381 | Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. |
| Q82676429 | Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain |
| Q49017826 | Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland |
| Q64878797 | Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach |
| Q35230264 | Control of electrolyte transport in the kidney through a dopamine‐ and CAMP‐regulated phosphoprotein, DARPP‐32* |
| Q38177261 | Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. |
| Q33269476 | Convergence of synaptic inputs from the striatum and the globus pallidus onto identified nigrocollicular cells in the rat: A double anterograde labelling study |
| Q69375391 | Correlated light and electron microscopic study of dopaminergic neurons and their synaptic junctions with DARPP-32-containing cells in three-dimensional reaggregate tissue culture |
| Q37807297 | Current perspectives on the selective regulation of dopamine D2 and D3 receptors |
| Q56504158 | DARPP-32 Mediates the Actions of Multiple Drugs of Abuse |
| Q51556539 | DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes: implications for the regulation of type 2 deiodinase activity. |
| Q42517780 | DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons |
| Q48947150 | DARPP-32 development in the caudate nucleus is independent of afferent input from the substantia nigra |
| Q46642338 | DARPP-32 expression in rat brain after an inhibitory avoidance task |
| Q35449387 | DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib |
| Q48421856 | DARPP-32 involvement in the photic pathway of the circadian system. |
| Q28469090 | DARPP-32 is a robust integrator of dopamine and glutamate signals |
| Q52026697 | DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. |
| Q48826684 | DARPP-32 like protein in specific snail (Helix aspersa) neurones |
| Q22241668 | DARPP-32 mediates the actions of multiple drugs of abuse |
| Q39369730 | DARPP-32 to quantify intracerebral hemorrhage-induced neuronal death in basal ganglia |
| Q35201971 | DARPP-32, Jack of All Trades… Master of Which? |
| Q48638823 | DARPP-32, a dopamine and cyclic AMP-regulated phosphoprotein, is present in corticothalamic neurons of the rat cingulate cortex |
| Q69929488 | DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein in tanycytes of the mediobasal hypothalamus: distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements |
| Q28259380 | DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 |
| Q39698396 | DARPP-32, a dopamine-regulated phosphoprotein. |
| Q35598338 | DARPP-32-like immunoreactivity in AII amacrine cells of rat retina |
| Q35639141 | DARPP-32: an integrator of neurotransmission |
| Q26766237 | DARPP-32: from neurotransmission to cancer |
| Q90538452 | Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks |
| Q42989363 | Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons |
| Q48940810 | Detection and quantification of protein phosphatase inhibitor-1 gene expression in total rat liver and isolated hepatocytes |
| Q45127516 | Developmental regulation of phosphoprotein gene expression in the caudate-putamen of rat: an in situ hybridization study |
| Q34598251 | Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons |
| Q49120173 | Distribution and cellular localization of DARPP-32 mRNA in rat brain |
| Q28247832 | Distribution of DARPP-32 in the basal ganglia: an electron microscopic study |
| Q42453251 | Distribution of protein phosphatase inhibitor-1 in brain and peripheral tissues of various species: comparison with DARPP-32. |
| Q48324414 | Dopamine D1 agonist SKF 38393 increases the state of phosphorylation of ARPP-21 in substantia nigra |
| Q45290030 | Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease |
| Q91329780 | Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression |
| Q35941665 | Dopamine mechanisms and cocaine reward |
| Q60141581 | Dopamine: Functions, Signaling, and Association with Neurological Diseases |
| Q37692812 | Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs. |
| Q35741734 | Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling. |
| Q50863939 | FRETing over dopamine: single cell cAMP and protein kinase A responses to 100 ms dopamine application. |
| Q36226870 | Families of protein phosphatase 1 modulators activated by protein kinases a and C: focus on brain |
| Q36069142 | Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis |
| Q38863202 | Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer |
| Q39203598 | Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia |
| Q24681770 | Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition |
| Q24674131 | Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning |
| Q39298415 | Heterologous regulation of receptors on target cells of dopamine neurons in the prefrontal cortex, nucleus accumbens, and striatum |
| Q48432548 | Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain |
| Q42474249 | Immunocytochemical localization of phosphatase inhibitor-1 in rat brain |
| Q46169409 | Immunohistochemical Localization of DARPP-32 in the Brain of Two Lungfishes: Further Assessment of Its Relationship with the Dopaminergic System |
| Q42505422 | Immunohistochemical localization of DARPP-32 in the brain of the lizard, Gekko gecko: co-occurrence with tyrosine hydroxylase |
| Q42438955 | Immunohistochemical localization of DARPP-32 in the brain of the turtle, Pseudemys scripta elegans: further assessment of its relationship with dopaminergic systems in reptiles. |
| Q40942034 | In Vitro Differentiation of Human Neural Progenitor Cells Into Striatal GABAergic Neurons. |
| Q41200930 | In vivo stimulation of D1 receptors increases the phosphorylation of proteins in the striatum |
| Q45130529 | Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. |
| Q39337786 | Increased Expression of Slit2 and its Robo Receptors During Astroglial Scar Formation After Transient Focal Cerebral Ischemia in Rats. |
| Q41328174 | Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein. |
| Q69340296 | Inhibitors of protein phosphatase-1. Inhibitor-1 of bovine adipose tissue and a dopamine- and cAMP-regulated phosphoprotein of bovine brain are identical |
| Q48655861 | Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice |
| Q37687077 | Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse |
| Q44104351 | Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine |
| Q34016964 | Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). |
| Q42492921 | Localization of ARPP-90, a major 90 kiloDalton basal ganglion-enriched substrate for cyclic AMP-dependent protein kinase, in striatonigral neurons in the rat brain |
| Q37497139 | Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission |
| Q44985427 | Localization of DARPP-32 immunoreactive neurons in the bed nucleus of the stria terminalis and central nucleus of the amygdala: co-distribution with axons containing tyrosine hydroxylase, vasoactive intestinal polypeptide, and calcitonin gene-relate |
| Q42520354 | Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox |
| Q48346412 | Mating-related stimulation induces phosphorylation of dopamine- and cyclic AMP-regulated phosphoprotein-32 in progestin receptor-containing areas in the female rat brain. |
| Q48388865 | Modulation of the voltage-gated sodium current in rat striatal neurons by DARPP-32, an inhibitor of protein phosphatase |
| Q34383634 | Molecular components of striatal plasticity: the various routes of cyclic AMP pathways |
| Q41691971 | NCS-Rapgef2, the Protein Product of the Neuronal Rapgef2 Gene, Is a Specific Activator of D1 Dopamine Receptor-Dependent ERK Phosphorylation in Mouse Brain |
| Q42475169 | Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity |
| Q46084580 | Neural connectivity as an intermediate phenotype: brain networks under genetic control |
| Q37308026 | Neurocomputational models of basal ganglia function in learning, memory and choice |
| Q28372752 | Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice |
| Q42510880 | Neuronal localization of the tyrosine-specific protein kinase p62c-yes in rat basal ganglia |
| Q39473478 | Neuronal phosphoproteins. Mediators of signal transduction |
| Q42457852 | Neuronal phosphoproteins: physiological and clinical implications |
| Q36245651 | Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra |
| Q43751783 | Oestradiol increases phosphorylation of a dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32) in female rat brain |
| Q37041675 | Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes) |
| Q44519012 | Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum |
| Q50298504 | PKA phosphorylates DARPP-32 on Thr34 |
| Q36292594 | Pass the nitric oxide |
| Q34325365 | Pathophysiology of levodopa-induced dyskinesia: potential for new therapies |
| Q34126949 | Pharmacology of signaling induced by dopamine D(1)-like receptor activation |
| Q37462899 | Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells |
| Q40222621 | Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. |
| Q58112703 | Phosphorylation of DARPP-32, a Dopamine- and cAMP-regulated Phosphoprotein, by Casein Kinase Iin Vitroandin Vivo |
| Q37117611 | Phosphorylation of Rap1GAP, a striatally enriched protein, by protein kinase A controls Rap1 activity and dendritic spine morphology |
| Q39067400 | Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders |
| Q33632137 | Potential role of calcineurin for brain ischemia and traumatic injury |
| Q48489781 | Preprodynorphin-, preproenkephalin-, preprotachykinin A- and preprotachykinin B-immunoreactive neurons in the accumbens nucleus and olfactory tubercle: double-immunofluorescence analysis |
| Q33858047 | Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin |
| Q38395292 | Protein phosphorylation and neuronal function |
| Q40137416 | Protein phosphorylation in the brain |
| Q46438801 | Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex |
| Q48364102 | Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen |
| Q42155713 | Rapid NMDA receptor phosphorylation and oxidative stress precede striatal neurodegeneration after hypoxic ischemia in newborn piglets and are attenuated with hypothermia |
| Q33507917 | Rat DARPP-32: cloning, sequencing, and characterization of the cDNA. |
| Q28588042 | Regional distribution of DARPP-32 (dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of Mr = 32,000) mRNA in mouse brain |
| Q36699381 | Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum |
| Q58112094 | Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo |
| Q43715960 | Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| Q36095030 | Rhes: a GTP-binding protein integral to striatal physiology and pathology |
| Q36739445 | Role of Lipocalin-2 in Thrombin-Induced Brain Injury |
| Q34297126 | Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. |
| Q37903674 | Signaling from the cytoplasm to the nucleus in striatal medium-sized spiny neurons |
| Q42494842 | Spatial relationship of the striatonigral and mesostriatal pathways: double-label immunocytochemistry for DARPP-32 and tyrosine hydroxylase |
| Q36920938 | Stimulation of protein-tyrosine phosphorylation in rat striatum after lesion of dopamine neurons or chronic neuroleptic treatment |
| Q41345971 | Synapsin I, a phosphoprotein associated with synaptic vesicles: possible role in regulation of neurotransmitter release |
| Q40956724 | Synaptic transmission and modulation in the neostriatum |
| Q37150355 | The Intracellular Signaling Molecule Darpp-32 Is a Marker for Principal Neurons in the Cerebellum and Cerebellum-Like Circuits of Zebrafish |
| Q28567247 | The alpha and gamma 1 isoforms of protein phosphatase 1 are highly and specifically concentrated in dendritic spines |
| Q39189145 | The evolutionary strata of DARPP-32 tail implicates hierarchical functional expansion in higher vertebrates |
| Q40093368 | The functional significance of neurotransmitter diversity |
| Q28394570 | The internal state of medium spiny neurons varies in response to different input signals |
| Q41593397 | The involvement of DARPP-32 in the pathophysiology of schizophrenia |
| Q45247886 | The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern. |
| Q34100272 | The neurobiology of slow synaptic transmission |
| Q36833070 | The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses |
| Q35908686 | The role of DARPP-32 in the actions of drugs of abuse |
| Q35785906 | The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity |
| Q35255480 | The structure, role, and regulation of type 1 protein phosphatases |
| Q38558097 | The two-century journey of Parkinson disease research |
| Q74302740 | Third group of neostriatofugal neurons: neurokinin B-producing neurons that send axons predominantly to the substantia innominata |
| Q48591326 | Topographical distributions of 32K and 48K cAMP-regulated phosphoproteins: Relationships to dopamine and serotonin innervations in striatum, substantia nigra and cerebral cortex |
| Q37918798 | Unraveling the differential functions and regulation of striatal neuron sub-populations in motor control, reward, and motivational processes |
| Q37448108 | Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner |
| Q58542293 | cAMP regulation of protein phosphatases PP1 and PP2A in brain |
Search more.